A Study to Compare Two Bioanalytical Assays for Tebipenem

Clinical trial NCT05856747 · COMPLETED

Trial details

NCT number: NCT05856747
Sponsor: Spero Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2023-05-04
Primary completion: 2023-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.